Sell to Close your Amylin Pharmaceuticals January 20 (AQM +AD) call option at the market for a gain of more than 100 percent in just one week. Amylin Pharmaceuticals (AMLN) stock jumped this morning in the wake of a bullish report out of Bear Stearns, sending our option soaring. Read More
Our seasoned team of analysts continually monitors investment opportunities around the world, to provide investors with the widest possible array of money-making ideas.
Analyst Articles
BUY to Open the October 115 Oil Service HOLDRs call option (OIH+JC) at $5.00 or below. After backing down from the recent highs of $67.10/barrel, oil prices are back to their uptrend. Last Wednesday's inventory report that caused the biggest selloff in months, was not, in fact, that bearish. Read More
Buy to open the October 190 Merrill Lynch Biotech HOLDRs Trust call option (GBZ + JR). Set a limit to pay no more than $8.00 for the option. For much of this year biotech stocks have been clear standouts in what has otherwise been a lackluster market. Read More
Buy to open the October 190 Merrill Lynch Biotech HOLDRs Trust call option (GBZ + JR). Set a limit to pay no more than $7.60 for the option. For much of this year biotech stocks have been clear standouts in what has otherwise been a lackluster market. Read More
BUY to Open the October 115 Oil Service HOLDRs call option (OIH+JC) at $4.40 or below. Read More
Buy to open the January 120 Merrill Lynch Oil Service Index HOLDRS Trust (OIH + AD) call option. Set a limit to pay no more than $8 for the option. Read More
Buy to Open the Amylin Pharmaceuticals January 20 (AQM +AD) call option. Set a limit order to buy at no more than $3.80. Our old friend Amylin Pharmaceuticals (AMLN) is back in our sights. After pulling back from its highs, the share price of this maker of two novel diabetic drugs is perking up again following a positive write-up in this week’s Barron’s. Read More
Buy to Open the Amylin Pharmaceuticals January 20 (AQM +AD) call option. Set a limit order to buy at no more than $3.80. Our old friend Amylin Pharmaceuticals (AMLN) is back in our sights. After pulling back from its highs, the share price of this maker of two novel diabetic drugs is perking up again following a positive write-up in this week’s Barron’s. Read More
August 12, 2005 Sell to close your September 90 XAU call option (XAU + IR) at the market for a gain of about 80 percent in a little over five weeks. The precious metals staged an impressive rally yesterday and the gold and silver mining stocks rose accordingly. Read More
August 11, 2005 Sell to close the Coeur d'Alene Mines September 2.50 call option (CDE + IZ) at the market, for a profit of about 40 percent. Precious metals have been moving up as expected and handing us nice gains on our two precious metals plays in the process. Read More